UNH Long $400 - Wyckoff Re-Accumulation SchematicWyckoff Re-Accumulation on UNH after recent ER sell off. Look for $400 to be supportive. Potentially an excellent addition the long term portfolio.
NYSE:UNH
UNH trade ideas
$UNH Rinse & Repeat Round #2- Fundamentally it's undervalued for the quality blue chip company. My detailed analysis is on the older post I made earlier this year. I have attached that as a reference.
- In my previous swing, I bought NYSE:UNH on a sell off @ 441 and sold @600 before earning as a de-risking strategy. I'm glad that it did work out.
- I'm happy that NYSE:UNH is again trading at a discount and with compressed Earning multiple. This time I am buying it even lower than where I bought last time i.e 441 and I was happy with that price average.
- Whereas I do believe that NYSE:UNH EPS is lowered but it is lowered slightly which doesn't warrant a big sell off like this.
- I wanted to wait further before entering but I can't stop myself from buying this name NYSE:UNH at a price where I believe it's very undervalued.
- Therefore, I have re-entered the NYSE:UNH and added it to my portfolio . I will consider adding further if selling pressure continues because I don't want to time the bottom.
- But undecisive market and lumpy market, going with a defensive name like this is a no brainer.
Trading idea: Buying at $396 and selling at $483Trading idea: Buying at $396 and selling at $483.
Just a trade my friend.
UNH eyes on $579.28: Genesis fib for possible bullish supportUNH testing a Genesis fib at $579.28.
This might get a decent bounce here.
Ultra-Bull if breaks Golden at $592.60.
UNH close to pivotUNH finds itself right on the 100 monthly EMA which is an insane moving average to touch. The stock has also corrected into the golden pocket between the .5-.618 fib which is one of my favorite setups especially on weekly plus timeframes. The last time advanced stochastic was this low was the 2008 financial crisis.
Net long here, would love 375 but as this is a monthly chart the buy signal is now
Dont jump to buy United Healthcare - LongUnited healthcare a leading insurance provider with around 15% market share will be a good buy but wait for it drop more and settle around 280-240$ which was the previous resistance prior to covid. Wait and buy at those levels for long term portfolio.
UNH: $250 18x in 10 years health is an investment
invest in a company that is dominating across the universe and setting up shops in emerging markets
UNH Sitting on supportThis level shows a major support level with all the rejections. Currently I’m seeing a falling wedge the broke the trend line (not the previous lower high)resistance last month and is currently retesting that line. More or less with the last 2 consolidations price had to move sideways in the channel for a continuation of a healthy up move. We may see a short term down from here but expect price to close at the $505 level eom. I’m in at $450.15.
UnitedHealth (UNH) Share Price PlummetsUnitedHealth (UNH) Share Price Plummets
UnitedHealth shares crashed by nearly 23% yesterday after the healthcare giant reported weaker-than-expected Q1 2025 results:
→ Earnings per share: actual = $7.20, expected = $7.29
→ Revenue: actual = $109.5bn, expected = $111.5bn
Technical Analysis of UNH Share Chart
As far back as a year ago, we highlighted key support around the $450 level. Yesterday’s negative news caused this support to once again demonstrate its strength by holding back further decline — but will it hold?
Taking the price action marked on the chart as a base, we can establish the structure of a descending channel (shown in red), with the price gapping sharply lower into the bottom half of this channel — and yesterday’s candle high (marked with an arrow) suggests that the median line has turned into resistance.
Yesterday’s candle closed near its lows, so it is reasonable to assume that bearish pressure may persist (with the aim of testing the lower boundary) — in which case, the $450 support zone, in place since early 2022, could be at risk.
This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
$UNH buy the fear or sell into narrative?- NYSE:UNH has gotten into trouble with bad headlines after bad headlines.
- Recent DOJ probe led to 12% shaving in the stock price.
- Could it be a buying opportunity or just a falling knife?
- Are you afraid that NYSE:UNH could become NYSE:HUM 2.0?
Let's talk about fundamentals!
Year | 2024 | 2025 | 2026 | 2027 | 2028
GAAP EPS | 15.76. | 28.22 | 32.11 | 36.80 | 41.11
EPS growth% | -33.47% | 79.08% | 13.77% | 14.61% | 11.71%
It appears that 2024/ Early 2025 was the year when EPS growth bottomed and would go from negative to positive back again.
EPS growth is healthy double digit in mid teens. A fair forward p/e multiple for mid teen EPS growth should at least be 15 ( conservatively )
Year | 2024 | 2025 | 2026 | 2027 | 2028
Fair Stock Price (w/ forward p/e = 15 ) | $236 | $423 | $481 | $552 | $616
However, NYSE:UNH is a blue chip company and has a moat. Therefore, Investors will be willing to pay forward p/e of 20 once negative news subside.
Year | 2024 | 2025 | 2026 | 2027 | 2028
Fair Stock Price (w/ forward p/e = 20 ) | $315 | $564 | $642 | $736 | $822.2
Final Take:
I'm a buyer of NYSE:UNH < 450 will add more if it dips below 400 for the long term. Good quality companies don't usually buyers to get their skin into the game. Therefore, it's better to buy the fear than selling into narrative.
UNH: Corrective wave coming to an endAfter the steep selloff for UNH, it has seen a significant bounce to the previous resistance level - this was aided by the fact that UNH because a popular tarriff counter trade, with money pouring in to what has been considered a safe haven in times of trade war turbulence. There space to run some more but its likely that UNH will run out of steam soon and retest support levels at ~480 and ~450.
Broke out of resistance last time, slow down this timeOverbought oscillators, turning over bearish sentiment, could see a correction that drops to the upper 400s with a sentiment shift.
$UNH: UnitedHealth Group – Healthcare Hero or Reform Risk?(1/9)
Good evening, everyone! 🌙 NYSE:UNH : UnitedHealth Group – Healthcare Hero or Reform Risk?
With UNH at $505.69, post-7% drop, is this healthcare giant a safe bet or a reform casualty? Let’s diagnose! 🔍
(2/9) – PRICE PERFORMANCE 📊
• Current Price: $ 505.69 as of Mar 18, 2025 💰
• Recent Move: Stable after 7% drop, per user data 📏
• Sector Trend: Healthcare sector mixed with reforms and economic factors 🌟
It’s a steady pulse—let’s see if it’s time to buy or hold! ⚙️
(3/9) – MARKET POSITION 📈
• Market Cap: Approx $465B (920M shares) 🏆
• Operations: Health insurance and services across the U.S. ⏰
• Trend: Leading player with strong fundamentals, per data 🎯
Firm in healthcare, but reforms keep it on its toes! 🏥
(4/9) – KEY DEVELOPMENTS 🔑
• Mixed News: Healthcare reforms debated, earnings reports mixed, per user data 🌍
• Q4 2024 Earnings: Assume beat or miss based on context, per data 📋
• Market Reaction: Stabilized after drop, showing resilience 💡
Navigating through choppy waters! 🛳️
(5/9) – RISKS IN FOCUS ⚡
• Healthcare Reforms: Regulatory changes could impact business 🔍
• Competition: Other insurers and providers in the market 📉
• Economic Slowdown: Reduced consumer spending on healthcare ❄️
It’s a risky prescription—watch the side effects! 🛑
(6/9) – SWOT: STRENGTHS 💪
• Market Leader: Dominant in U.S. healthcare 🥇
• Diversified Portfolio: Insurance and services balance risk 📊
• Financial Strength: Strong earnings and cash flow, per data 🔧
Got the muscle to handle challenges! 🏦
(7/9) – SWOT: WEAKNESSES & OPPORTUNITIES ⚖️
• Weaknesses: Regulatory scrutiny, high debt (if any) 📉
• Opportunities: Aging population, tech advancements in healthcare, per data 📈
Can it capitalize on growth or stumble on weaknesses? 🤔
(8/9) – POLL TIME! 📢
UNH at $505.69—your take? 🗳️
• Bullish: $600+ soon, reforms are manageable 🐂
• Neutral: Steady, risks balance out ⚖️
• Bearish: $450 looms, reforms hit hard 🐻
Chime in below! 👇
(9/9) – FINAL TAKEAWAY 🎯
UNH’s $505.69 price reflects stability after a drop, with mixed news and reforms in play 📈. DCA-on-dips could be a strategy to manage volatility. Gem or bust?
$UNH - WHOLESALE/BUYING OPPORTUNITYUnitedHealth Group: A Leader in Healthcare Services
UnitedHealth Group is a healthcare giant that provides a wide range of services, from health insurance to data consultancy. Let's break down its four main segments:
UnitedHealthcare: Focuses on improving patient care, affordability, and effectiveness through Optum's capabilities.
OptumHealth: Offers health and wellness care services to payers, care providers, employers, government, life sciences companies, and consumers.
OptumInsight: Provides data and analytics, technology, and information to major healthcare industry participants.
OptumRx: Offers pharmacy care services.
A Commitment to Innovation
UnitedHealth Group was founded in 1977 by Richard T. Burke and has since grown to become a global leader in healthcare services. With a focus on innovation and improvement, the company continues to shape the healthcare landscape.
What do you think are the most important aspects of healthcare services? Share your thoughts in the comments!
UnitedHealth was showing lack of strength BEFORE this fallAstute chart traders saw the underlining weakness BEFORE this possible horrible opening for UnitedHealth Group.
Clues were there NOT to be long for a while now.
The Ugly Truth of Technical Analysis...Even though this may be an extremely unpopular opinion on this topic, realizing this simple truth may be what makes or breaks a profitable trader. The truth is this...
Drawing lines on a chart does not predict any price movement, and there are more factors in play than simply price action
It doesn't matter what the gurus on the internet say about some "secret strategy" or a "secret indicator", anyone with common sense should automatically ignore content like that. Firms like NYSE:JPM , NYSE:GS , NYSE:MS , etc. , spend billions upon billions of dollars just to figure out how to trade the market with efficiency, but some random 19 year old on the internet figured out how to beat these mega-firms with a free indicator. Yeah right.
However, I'm not saying that technical analysis doesn't work or that it shouldn't be used; I'm simply saying to reconsider your strategy and use common sense before donating your money to Wall Street banks. Below is an example of technical analysis working perfectly on NYSE:UNH for the 1D timeframe looking back into April of last year.
This would have been a textbook channel breakout trade, in which the trader takes a short when the bottom trendline is broken (or the candle closes below the trendline). It would have resulted in a maximum of 17% gain on naked short shares if the bottom penny is the exit price (which is virtually impossible). So there you have it... technical analysis works perfectly and I have proven myself wrong.... right? No. . Now let me show you what really happened. Here is the same exact chart, but this time with a piece of key information shown.
As it turns out, there was nothing technical in play at all in this price action, but rather a "fundamental" or a "tangible" aspect was the price driver. An example like this should also show you that not providing sufficient information and taking charts out of context can be done by literally anyone. If you think you can predict the future with some geometric shapes, bars, and non financial, fundamental, or tangible analysis, better than the top Wall Street firms, I say good luck to you.
WITH THAT BEING SAID, this does not mean that trendlines, price areas, value gaps, and other technical indicators are completely invalid, but it does mean that there is more to the story than what is on the chart. Always review news, sentiment, financials, analyst ratings, and other key oscillators to gauge every trade.
Disclaimer: The indicators used on the chart are only for illustrative purposes of a cluttered chart. I am neither saying that they are accurate nor inaccurate.
UNH Stock Analysis: Potential Reversal Zone in a Downward ImpulsNYSE:UNH (UnitedHealth Group) appears to be in a downward impulsive wave, currently within the fifth wave. I anticipate a potential bounce near the blue horizontal line, which could act as a key support level.
This analysis highlights a possible reversal zone, but keep in mind that this is not financial advice or a recommendation to buy or sell. Always monitor price action and volume closely to confirm any movement.
#UNH
#StockAnalysis
#TechnicalAnalysis
#TradingView
#StockMarket
#ElliottWave
#SwingTrading
$UNH Earnings: First Report Since Tragedy in NYCUnitedHealth ( NYSE:UNH ) reports tomorrow at 5:55 AM ET with Wall St. expecting EPS of $6.92 and revenue of $101.1B. The company has consistently beaten estimates over the past 2 years. From 2013-2023, EPS grew from $5.59 to $24.12.
Key focus areas: medical cost trends, Medicare Advantage growth, and the impact of leadership changes following recent events. This quarter’s call will attract more than just investors.
UNH - Took the GREEN PILL! 15% Move Inbound!NYSE:UNH 💊
H5_Swing Trade:
Playing small with one $560 Call heading into earnings. Fundamentally undervalued and beaten down stock since their CEO was murdered.
Good earnings and the fact they are a safety play make me really like this play.
H5 Trade and WCB look great too!
🎯$623
⏳Before March
Not financial advice
UNITEDHEALTH GROUP | THE BEAR'S CLAIM: $UNH PAYS THE PRICE Dec17UNITEDHEALTH GROUP | THE BEAR'S CLAIM: NYSE:UNH PAYS THE PRICE Dec17
UnitedHealth Group, NYSE:UNH , UNH
NYSE:UNH Trends:
NYSE:UNH Weekly Trend: Bearish
NYSE:UNH Daily Trend: Bearish
NYSE:UNH 4H Trend: Bearish
NYSE:UNH 1H Trend: Bearish
NYSE:UNH Price Target Areas:
NYSE:UNH BUY/LONG ZONE (GREEN): $488.75 - $514.75
NYSE:UNH DO NOT TRADE/DNT ZONE (WHITE): $480.00 - $488.75
NYSE:UNH SELL/SHORT ZONE (RED): $455.00 - $480.00
All indicators are pointing to bearish for $UNH. Looking at the monthly timeframe we can see there is a range that was respected between the levels of 480 up to 555. After price finally broke the level of 555 a new range began. 560 up to 615/620 area. Given the recent news and events; the stock has since seen a deep bearish trend. Momentum has taken price all the way back down to the previous range low of 480. Price currently rests on 480. Bears should seek continuation and target levels of 455/460, or even down to 415. Bulls should look for a reversal marked by breaks over 488.75 on the lower timeframes, or the 549 area for a higher frame reversal.
This is what I would personally look at before entering trades, everything is subject to change on a daily basis and as I analyze different timeframes and ideas.
ENTERTAINMENT PURPOSES ONLY, NOT FINANCIAL ADVICE!
trendanalysis, trendtrading, priceaction, priceactiontrading, technicalindicators, supportandresistance, rangebreakout, rangebreakdown, rangetrading, chartpatterntrading, chartpatterns, unh, unitedhealth, unitedhealthgroup, NYSE:UNH , insurance, insuranceclaims, unhinsurance, unhclaims, unhdeductible, unhstock, unhprice, unhtarget, unhsetup, unhtrade, unhzone, medicare, unhanalysis, unitedhealthanalysis, unhtradeidea, unhidea, unhrecentevents,
Bullish on UnitedHealth Group. UNHMajor confluence of factors here to suggest a bullish bias. MIDAS curve cross shortly after Ehrler's Smoother cross. Suspect B Wave start in a flat zigzag. Ehrler's stochastic and VZO remain bullish, yet less convincingly.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green or purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line.
Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis.
Professionally, we are big fans of any indicators from Jurik, De Mark and Ehlers, which we use in addendum in analysis prior to putting down positions.
We prefer a combination of at least four technical factors to favor a particular stance. A stance is never decided by this constellation, rather the constellation merely confirms the stance.
Trading is a true one man sport. No single confluence of indicators is truly good enough, and a professional trader's sense must be developed through a lot of hard work and over a significant period of time. Good luck out there and stay safe.
United Health Group - Innovation in the Medical BusinessHi guys, off to our next analisys we would be taking a look into UNH.
UnitedHealth Group continues to shine as a leader in the healthcare industry, showcasing exceptional financial health and a promising future. The company's strong financial performance, driven by innovative solutions and a focus on operational excellence, reflects its ability to adapt and thrive in a complex and ever-changing market.
UnitedHealth Group's dedication to improving healthcare outcomes through technology and data-driven approaches sets it apart. Their forward-looking investments in cutting-edge medical advancements and digital health tools demonstrate a commitment to delivering accessible, high-quality care for individuals and communities.
The company’s diversified business model, spanning insurance services and healthcare delivery, provides a solid foundation for sustained growth. Their strategic initiatives, including expanding partnerships and entering new markets, further position them as a trailblazer in the healthcare sector.
UnitedHealth Group's unwavering focus on customer-centric solutions, combined with its financial strength and visionary leadership, ensures a future of continued success. For stakeholders and investors, UnitedHealth Group is not only a secure choice but also an inspiring partner in shaping the future of healthcare.
My entry would be: 500
I would enter with 300 shares
Target 1: 553
Target 2: 625
As always my friends happy trading!
P.S. If you have questions or inquiries about one of my existing set-ups or personal questions / 1 on 1 sessions consider joining my community so you can follow up with me in private!
UnhHealth sector has gotten demolished in the last month with RFK jr. Appointment..
Didn't help that this company has had some bad news the last 2weeks..
Technically, UNH tagged it's weekly 200sma at 470.. UNH hasnt broken it's weekly 200sma since 2008-09 crash..
Also the double top that added fire to this sell is completed
.. I think healthcare sector and particularly this stock rebounds to the 20sma at 550 over the next 2 weeks
